20 Jul, 2022 ILLUMINATE-C Phase 3 Results for Lumasiran Published in American Journal of Kidney Diseases
Posted at 09:27h
in Capella
Results from the six-month primary analysis of the ongoing ILLUMINATE-C Phase 3 study of lumasiran in patients of all ages with primary hyperoxaluria type 1 (PH1) and advanced kidney disease were published online in the American Journal of Kidney Diseases.
Read the paper in the American Journal of Kidney Diseases
